About the company
Sichuan Hebang Biotechnology Co., Ltd., formerly Sichuan Hebang Corporation Limited, is a China-based company, principally engaged in the manufacture of chemical products. The Company operates its businesses through three segments, including Agriculture segment, Chemical segment and New Materials segment. The Agriculture segment provides chemical pesticides, feed nutrients, biological pesticide machines and other biological products. The Chemical segment provides sodium carbonate, sodium chloride, salt and phosphate. The New Materials segment provides smart glass, specialty glass and carbon fibers. It distributes its products within domestic market and to overseas markets.
- Revenue in CNY (TTM)8.43bn
- Net income in CNY916.48m
- Incorporated2002
- Employees7.17k
- LocationSichuan Hebang Biotechnology Co LtdMianba VillageNiuhua Town, Wutongqiao DistrictLESHAN 614801ChinaCHN
- Phone+86 2 862050230
- Fax+86 2 862050290
- Websitehttps://www.hebang.cn/
- Forums
- ASX - By Stock
- AEV
- Ann: Strategic Investment from Sichuan Hebang Biotechnology
Ann: Strategic Investment from Sichuan Hebang Biotechnology, page-98
-
- There are more pages in this discussion • 175 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AEV (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.33M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.9¢ | $7.105K | 789.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 2127381 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 896694 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 2127381 | 0.009 |
7 | 720000 | 0.008 |
4 | 1442142 | 0.007 |
8 | 21007328 | 0.006 |
2 | 1500001 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 896694 | 3 |
0.011 | 1683566 | 4 |
0.012 | 559923 | 5 |
0.013 | 152257 | 2 |
0.014 | 2440000 | 5 |
Last trade - 15.54pm 13/11/2024 (20 minute delay) ? |
Featured News
AEV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online